Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CTSC - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
S100A2 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
GLIPR1 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
CAV1 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
KLK5 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
VEGFC - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
CLDN1 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
OLR1 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
TFF1 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
CXCL2 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
TGFB2 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
ITGBL1 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
EDN1 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
LAMC2 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
ANXA3 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
SSPN - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
TAGLN - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on